Pre-exposure prophylaxis reduces risk of COVID-19

Nature Reviews Rheumatology, Published online: 03 October 2023; doi:10.1038/s41584-023-01039-8In an observational study, SARS-CoV-2 antibody therapy used as pre-exposure prophylaxis reduced the incidence of COVID-19 in individuals with rheumatic diseases.

Source: Nature Reviews Rheumatology - October 3, 2023 Category: Rheumatology Authors: Sarah Onuora Source Type: research